Nan Fang
方南
Nan Fang is the founder and CEO of Singleron (新格元), a single-cell sequencing company, as noted in a 2021 FreeS Fund investor summit recap . elsewhere's corpus does not otherwise cover this person in depth — no dedicated profile or biographical material appears in the retrieved bundle.
AI-generated — may contain errors, please verify.
Coverage
The 6 Questions Young People Care About Most: We Asked 17 Founders | FreeS Fund Youth Festival & Graduation Season Special
Passion and conviction are what carry you through the darkness.
MaKe | Four MaHui Member Company Executives Named to Forbes China's "2023 Businesswomen to Watch" List
Businesswomen are working new wonders for China's economy
Women Rising: 18 Voices from the World of Entrepreneurship | FreeS Fund International Women's Day Special
The traits that lead to success know no gender. May your journey of discovery be filled with wonder.
How Does Single-Cell Sequencing Help You Understand the 40 Trillion Cells in Your Body? | 2021 FreeS Fund Annual Investor Summit
How Single-Cell Sequencing Is Revolutionizing Biomedicine
FreeS Fund Sets Up Shop in Shanghai, New Office Now Operational
FreeS Fund opens offices in both the north and south, choosing to do what's right rather than what's easy.
Be Long-Term Greedy, Be a True Hero | FreeS Fund 2019 CEO Annual Meeting
Let's Go Further Together
FreeS Fund II Completes First Close, New Launches, Awards... 13 Updates and 4 Insights | FreeS Fund Blackboard · September
Stay grounded, keep pushing forward.
Singleron Biotechnologies Closes Tens of Millions of RMB in Angel Round to Accelerate Commercialization of Single-Cell Analysis Technology | FreeS Fund News
Making single-cell analysis a routine part of clinical practice.
